Journals / Kulak Burun Boğaz ve Baş Boyun Cerrahisi / 2020 / Cilt: 28 - Sayı: 3

The Analysis of Late-Term Otologic Complications Secondary to Treatment and Treatment Methods of Complications in Patients with Nasopharyngeal Cancer

Nazofarenks Kanseri Olgularında Tedaviye Sekonder Geç Dönem Otolojik Komplikasyonların ve Komplikasyon Tedavi Yöntemlerinin Analizi

Pages
173–180
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this population, early precautions and conservative treatment approaches should be applied to prevent ear pathologies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Due to the high radiotherapy doses, large irradiated areas, ototoxic chemotherapy drugs in treatment protocols, young patient age, and good prognosis; the complications secondary to the treatment in patients with nasopharyngeal cancer (NFC) are common.
📊
Key Findings & Data:Material and Methods: Between 1996-2016, 61 patients (122 ears) who were treated and followed at a tertiary clinic of otorhinolaryngology, radiation oncology and medical oncology clinic with the diagnosis of NFC were included in the study.
💡
Conclusion & Impact:In this population, early precautions and conservative treatment approaches should be applied to prevent ear pathologies.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Due to the high radiotherapy doses, large irradiated areas, ototoxic chemotherapy drugs in treatment protocols, young patient age, and good prognosis; the complications secondary to the treatment in patients with nasopharyngeal cancer (NFC) are common. In this study; it was aimed to evaluate otologic complications secondary to NFC treatment and the treatment methods of these complications in NFC cases followed up in our clinic, and to provide a clinical perspective on this issue. Material and Methods: Between 1996-2016, 61 patients (122 ears) who were treated and followed at a tertiary clinic of otorhinolaryngology, radiation oncology and medical oncology clinic with the diagnosis of NFC were included in the study. The patients were evaluated in terms of demographic features, otoscopic examination findings, audiometry tests, and treatment methods. Results: Of the patients, 44 (72%) were male and 17 (28%) were female. The median age was 48 (age range: 19-65). The complications were most common in the outer ear (n=107, 87.7%), followed by the middle ear (n=81, 66.4%), and the inner ear (n=72, 59.0%), respectively. The most common pathology in the outer ear was skin atrophy (n=101, 82.7%). followed by chronic external otitis (n=5, 4.1%), and outer ear stenosis (n=2, 1.6%) were observed. Adhesive otitis media (n=31, 25.4%) is the most common in middle ear pathologies, then eeustachian tube dysfunction corrected with The Valsalva maneuver (n=30, 24.6%), myringosclerosis (n=29, 23.8%), respectively. Hearing loss was observed in 89 (72.9%) ears. The most common hearing loss type was mixed type hearing loss (n=43, 35.2%). Subsequently, sensorineural hearing loss (SNHL) (n=32, 26.2%) and conductive type hearing loss (n=14, 11.5%) were observed, respectively. SNHL was also present in 40 (32.8%) patients when evaluated for a decrease in bone pathway after 2 kHz. Conservative methods were frequently used in the treatment. Conclusion: In cases of NFC, the entire hearing pathway may be affected in otological complications secondary to radiotherapy. Ear pathologies that can improve with conservative treatment and in early-stage are more common. In the long term, middle ear pathologies are the main problems of this group of patients. In this population, early precautions and conservative treatment approaches should be applied to prevent ear pathologies.

Özet

Amaç: Nazofarenks kanseri (NFK) olgularında, tedaviye sekonder kulak komplikasyonları; yüksek radyoterapi dozları, geniş ışınlanan alanlar, tedavi protokollerinde ototoksik kemoterapi ilaçlarının yer alması, genç hasta yaşı ve iyi prognoz nedeni ile sık görülür. Bu çalışmada; kliniğimizde takibi yapılan NFK olgularında, tedaviye sekonder kulak komplikasyonlarını ve bu komplikasyonların tedavi yöntemlerini değerlendirmek, bu konuda klinik bir bakış açısı sağlamak amaçlanmıştır. Gereç ve Yöntemler: NFK tanısıyla 1996-2016 yılları arasında, bir 3. basamak sağlık merkezinin kulak-burun-boğaz hastalıkları, radyasyon onkolojisi ve medikal onkoloji kliniklerinde tedavi ve takipleri yapılan 61 hasta (122 kulak) çalışmaya dâhil edildi. Hastalar demografik özellikler, otoskopik muayene bulguları, odyometri testi ve tedavi yöntemleri yönünden değerlendirildi. Bulgular: Hastaların 44 (%72)’ü erkek, 17 (%28)’si kadın idi. Ortanca yaş 48 (yaş aralığı: 19-65) idi. Komplikasyonlar, en sık dış kulakta (n=107, %87,7); 2. sıklıkta orta kulakta (n=81, %66,4); en az sıklıkta iç kulakta (n=72, %59,0) izlendi. Dış kulak patolojilerinde en sık cilt atrofisi (n=101, %82,7); sonra sırasıyla kronik eksternal otit (n=5, %4,1), dış kulak yolu stenozu (n=2, %1,6) izlendi. Orta kulak patolojilerinde en sık adeziv otitis media (n=31, %25,4); sonra sırasıyla Valsalva Manevrası ile düzelen östaki tüp disfonksiyonu (n=30, %24,6), miringoskleroz (n=29, %23,8) izlendi. İşitme kaybı 89 (%72,9) kulakta izlendi. En sık işitme kaybı, mikst tip işitme kaybı (n=43, %35,2) idi. Takiben sırasıyla sensörinöral tip işitme kaybı(SNİK) (n=32, %26,2) ve iletim tipi işitme kaybı (n=14, %11,5) izlendi. SNİK, ayrıca 2 kHz sonrası kemik yolunda düşüş açısından değerlendirildiğinde, 40 (%32,8) hastada mevcuttu. Tedavi yöntemlerinde, sıklıkla konservatif yöntemler uygulandı. Sonuç: NFK olgularında, radyoterapiye sekonder otolojik komplikasyonlarda, tüm işitme yolağı etkilenebilir. Erken evre ve konservatif tedavi ile iyileşme sağlanabilecek kulak patolojileri daha sık görülmektedir. Orta kulak patolojileri, bu hasta grubunun uzun dönemde en temel problemlerindendir. Bu popülasyonda, kulak patolojilerini engellemek için erken önlemlerin alınması ve konservatif tedavi yaklaşımlarının uygulanması gerekmektedir.

🔖

Cite This Article

ANT, A., DURAN, A., ATABEY, P., YAZICI, Ö., ASLAN, F. F., ÖZLÜGEDİK, S. (2020). The Analysis of Late-Term Otologic Complications Secondary to Treatment and Treatment Methods of Complications in Patients with Nasopharyngeal Cancer. Kulak Burun Boğaz ve Baş Boyun Cerrahisi, Cilt: 28 - Sayı: 3, 173–180. https://ajindex.com/articles/346575

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Brinkmeier JV, Heider A, Brown DJ. Pediatric head and neck malignancies. In: Flint PW, Haughey BH, Lund VJ, Niparko JK, Robbins KT, Thomas JR, et al., eds. Cummings Otolaryngology-Head and Neck Surgery. 6th ed. Philadelphia, PA: Elsevier, Saunders; 2015. p.3089
  2. Low WKC, Rangabashyam M. Ear-related issues in patients with nasopharyngeal carcinoma. In: Chen SS, ed. Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma. Croatia: InTech; 2012. p.155-78.[Link] 3. Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R. Radiotherapy-induced ear toxicity. Cancer Treat Rev. 2003;29(5):417-30.[Crossref] [PubMed] 4. Veterans Affairs Fact Sheet. Nasopharyngeal Radium Therapy. VA Office of Public Affairs News Service, Washington DC, Feb. 1999. [Link] 5. Sataloff RT, Rosen DC. Effects of cranial irradiation on hearing acuity: a review of the literature. Am J Otol. 1994;15(6):772-80.[PubMed] 6. Borsanyi SJ, Blanchard CL. Ionizing radiation and the ear. JAMA. 1962;181:958-61.[Crossref] [PubMed] 7. Young YH. Irradiated ears in nasopharyngeal carcinoma survivors: a review. Laryngoscope. 2019;129(3):637-42.[Crossref] [PubMed] 8. Takasaki K, Hirsch BE, Sando I. Histopathologic study of the human eustachian tube and its surrounding structures following irradiation for carcinoma of the oropharynx. Arch Otolaryngol Head Neck Surg. 2000;126(4):543- 6.[Crossref] [PubMed] 9. Bohne BA, Marks JE, Glasgow GP. Delayed effects of ionizing radiation on the ear. Laryngoscope. 1985;95(7 Pt 1):818-28.[Crossref] [PubMed] 10. Wu LR, Liu YT, Jiang N, Fan YX, Wen J, Huang SF, et al. Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: an analysis of 614 patients from a single center. Oral Oncol. 2 11. Ant A, Yazici Ö, Atabey P, Aslan FF, Duran A, Ozlugedik S, et al. Is intensity-modulated radiotherapy superior to conventional techniques to prevent late ear complications of nasopharyngeal cancer? Eur Arch Otorhinolaryngol. 2019;276(4):977-84.[Crossref] [PubMed] 12. Yao JJ, Zhou GQ, Lin L, Zhang WJ, Peng YL, Chen L, et al. Dose-volume factors associated with ear disorders following intensity-modulated radiotherapy in nasopharyngeal carcinoma. Sci Rep. 2015;5:13525.[Crossref] [PubMed] [PMC] 13. Li JJ, Guo YK, Tang QL, Li SS, Zhang XL, Wu PA, et al. Prospective study of sensorineural hearing loss following radiotherapy for nasopharyngeal carcinoma. J Laryngol Otol. 2010;124(1):32-6.[